Carsten Bokemeyer
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG).
Seidel C, Hentrich M, Zschäbitz S, Paffenholz P, Heidenreich A, Nestler T, Tran B, Fischer S, Daugaard G, Ochsenreither S, Brito M, Zengerling F, Schwab C, Bokemeyer C, Oing C. Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG). World J Urol 2022; 40:355-361.
07.01.2022Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG).
07.01.2022World J Urol 2022; 40:355-361
Seidel Christoph, Hentrich Marcus, Zschäbitz Stefanie, Paffenholz Pia, Heidenreich Axel, Nestler Tim, Tran Ben, Fischer Stefanie, Daugaard Gedske, Ochsenreither Sebastian, Brito Margarida, Zengerling Friedemann, Schwab Constantin, Bokemeyer Carsten, Oing Christoph
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Fankhauser C, Tandstad T, Nicolai N, Nicol D, Leão R, Muilwijk T, Janisch F, Mayor de Castro J, Gremmels H, Fizazi K, Fischer S, Boormans J, Bokemeyer C, Algaba F, Albers P, Oldenburg J, Pilar Laguna M. Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021. Eur Urol 2021; 80:4-6.
12.03.2021Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
12.03.2021Eur Urol 2021; 80:4-6
Fankhauser Christian Daniel, Tandstad Torgrim, Nicolai Nicola, Nicol David, Leão Ricardo, Muilwijk Tim, Janisch Florian, Mayor de Castro Javier, Gremmels Hendrik, Fizazi Karim, Fischer Stefanie, Boormans Joost L, Bokemeyer Carsten, Algaba Ferran, Albers Peter, Oldenburg Jan, Pilar Laguna M
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
Fischer S, Langberg C, Ståhl O, Fankhauser C, Hamid A, Koutsoukos K, Shamash J, White J, Bokemeyer C, Beyer J, Gillessen Sommer S, Wheater M, Hentrich M, Heidenreich A, Tandstad T, Cohn-Cedermark G, Thibault C, Vincenzi B, Klingbiel D, Albany C, Necchi A, Terbuch A, Lorch A, Aparicio J, Global Germ-Cell Cancer Group. Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. J Clin Oncol 2019:JCO1901876.
26.12.2019Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
26.12.2019J Clin Oncol 2019:JCO1901876
Fischer Stefanie, Langberg Carl W, Ståhl Olof, Fankhauser Christian Daniel, Hamid Anis A, Koutsoukos Konstantinos, Shamash Jonathan, White Jeff, Bokemeyer Carsten, Beyer Jörg, Gillessen Sommer Silke, Wheater Matthew, Hentrich Marcus, Heidenreich Axel, Tandstad Torgrim, Cohn-Cedermark Gabriella, Thibault Constance, Vincenzi Bruno, Klingbiel Dirk, Albany Costantine, Necchi Andrea, Terbuch Angelika, Lorch Anja, Aparicio Jorge, Global Germ-Cell Cancer Group
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Dieckmann K, Heinzelbecker J, Heidenreich A, Cremers J, Oing C, Hermanns T, Fankhauser C, Gillessen Sommer S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Ruf C, Loidl W, Haben B, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Belge G. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. J Clin Oncol 2019; 37:1412-1423.
15.03.2019Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
15.03.2019J Clin Oncol 2019; 37:1412-1423
Dieckmann Klaus-Peter, Heinzelbecker Julia, Heidenreich Axel, Cremers Jann Frederik, Oing Christoph, Hermanns Thomas, Fankhauser Christian Daniel, Gillessen Sommer Silke, Reichegger Hermann, Cathomas Richard, Pichler Martin, Hentrich Marcus, Eredics Klaus, Lorch Anja, Wülfing Christian, Peine Sven, Wosniok Werner, Bokemeyer Carsten, Ruf Christian Guido, Loidl Wolfgang, Haben Björn, Radtke Arlo, Geczi Lajos, Matthies Cord, Anheuser Petra, Eckardt Ulrike, Sommer Jörg, Zengerling Friedemann, Trenti Emanuela, Pichler Renate, Belz Hanjo, Zastrow Stefan, Winter Alexander, Melchior Sebastian, Hammel Johannes, Kranz Jennifer, Bolten Marius, Krege Susanne, Belge Gazanfer
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
Schittenhelm M, Bokemeyer C, Wong K, Corless C, Kanz L, Störkel S, Kurek R, Honecker F, Morich J, Harlow A, Oechsle K, Kollmannsberger C, Heinrich M. Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer. Mol Cancer Ther 2009; 8:481-9.
10.03.2009Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer
10.03.2009Mol Cancer Ther 2009; 8:481-9
Schittenhelm Marcus, Bokemeyer Carsten, Wong Kwok-Kin, Corless Christopher L, Kanz Lothar, Störkel Stephan, Kurek Raffael, Honecker Friedemann, Morich Jason, Harlow Amy, Oechsle Karin, Kollmannsberger Christian, Heinrich Michael C
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. European urology 2008; 53:478-96.
01.03.2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
01.03.2008European urology 2008; 53:478-96
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Ares Luis Paz, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Paz-Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. European urology 2008; 53:497-513.
01.03.2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
01.03.2008European urology 2008; 53:497-513
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Paz-Ares Luis, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
Cell-cycle progression and response of germ cell tumors to cisplatin in vitro
Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann J, Bokemeyer C, Mayer F. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Int J Oncol 2006; 29:471-9.
01.08.2006Cell-cycle progression and response of germ cell tumors to cisplatin in vitro
01.08.2006Int J Oncol 2006; 29:471-9
Mueller Sandra, Schittenhelm Marcus, Honecker Friedemann, Malenke Elke, Lauber Kirsten, Wesselborg Sebastian, Hartmann Joerg T, Bokemeyer Carsten, Mayer Frank
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies
Schittenhelm M, Druker B, Deininger M, Bokemeyer C, Lee F, Griffith D, Corbin A, Schroeder A, Shiraga S, Heinrich M. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 2006; 66:473-81.
01.01.2006Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies
01.01.2006Cancer Res 2006; 66:473-81
Schittenhelm Marcus, Druker Brian J, Deininger Michael W N, Bokemeyer Carsten, Lee Francis Y, Griffith Diana, Corbin Amie S, Schroeder Arin, Shiraga Sharon, Heinrich Michael C